Biomedical Chromatography 2010-10-01

Determination of piracetam in rat plasma by LC-MS/MS and its application to pharmacokinetics.

Xianqin Wang, Jiayin Zhu, Renai Xu, Xuezhi Yang, Haiya Wu, Dan Lin, Faqing Ye, Lufeng Hu

Index: Biomed. Chromatogr. 24(10) , 1108-12, (2010)

Full Text: HTML

Abstract

A sensitive and selective liquid chromatography-tandem mass spectrometry method for the determination of piracetam in rat plasma was developed and validated over the concentration range of 0.1-20 µg/mL. After addition of oxiracetam as internal standard, a simplified protein precipitation with trichloroacetic acid (5%) was employed for the sample preparation. Chromatographic separation was performed by a Zorbax SB-Aq column (150 × 2.1 mm, 3.5 µm). The mobile phase was acetonitrile-1% formic acid in water (10:90 v/v) delivered at a flow rate of 0.3 mL/min. The MS data acquisition was accomplished in multiple reaction monitoring mode with a positive electrospray ionization interface. The lower limit of quantification was 0.1 µg/mL. For inter-day and intra-day tests, the precision (RSD) for the entire validation was less than 9%, and the accuracy was within the 94.6-103.2% range. The developed method was successfully applied to pharmacokinetic studies of piracetam in rats following single oral administration dose of 50 mg/kg.Copyright © 2010 John Wiley & Sons, Ltd.


Related Compounds

  • Oxiracetam

Related Articles:

Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice.

1995-01-01

[Pol. J. Pharmacol. 47(1) , 69-73, (1995)]

Pre- and postprandial pyridostigmine and oxiracetam effects on growth hormone secretion in anorexia nervosa.

1996-10-01

[Psychoneuroendocrinology 21(7) , 621-9, (1996)]

Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.

1995-01-16

[Eur. J. Pharmacol. 272(2-3) , 203-9, (1995)]

Relationships between arousal and cognition-enhancing effects of oxiracetam.

1994-02-01

[Pharmacol. Biochem. Behav. 47(2) , 283-7, (1994)]

Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice.

1997-09-12

[Brain Res. 768(1-2) , 197-207, (1997)]

More Articles...